Concepedia

Tracy F. Gregory

TF

Statistics

Publications

9

Citations

436

H-Index

9

Active since

1997

Affiliations

Pfizer (United States)(Current)

Tracy F. Gregory is an author at Pfizer (United States) specializing in medicinal chemistry, pharmacology, and drug discovery.

Publications per year

1997–2009

9

Publications

9

Subtype-Selective <i>N</i>-Methyl-<scp>d</scp>-Aspartate Receptor Antagonists:  Synthesis and Biological Evaluation of 1-(Heteroarylalkynyl)-4-benzylpiperidines

Jonathan L. Wright, Tracy F. Gregory, Suzanne R. Kesten et al. · Journal of Medicinal Chemistry · 2000 · 110 citations

, , +16

Subtype-Selective <i>N</i>-Methyl-<scp>d</scp>-aspartate Receptor Antagonists:  Synthesis and Biological Evaluation of 1-(Arylalkynyl)-4-benzylpiperidines

Jon L. Wright, Tracy F. Gregory, Christopher F. Bigge et al. · Journal of Medicinal Chemistry · 1999 · 95 citations · Full text

, , +17

Benzothiophene piperazine and piperidine urea inhibitors of fatty acid amide hydrolase (FAAH)

Douglas S. Johnson, Kay Ahn, Suzanne R. Kesten et al. · Bioorganic & Medicinal Chemistry Letters · 2009 · 63 citations

, , +13

3-Arylimino-2-indolones Are Potent and Selective Galanin GAL<sub>3</sub> Receptor Antagonists

Michael J. Konkel, Bharat Lagu, Lakmal W. Boteju et al. · Journal of Medicinal Chemistry · 2006 · 49 citations · Full text

, , +9

Discovery of selective dopamine D4 receptor antagonists: 1-Aryloxy-3-(4-aryloxypiperidinyl)-2-propanols

Jon L. Wright, Tracy F. Gregory, Thomas G. Heffner et al. · Bioorganic & Medicinal Chemistry Letters · 1997 · 35 citations

, , +11

1–5 of 9